ASH AIA

Advocacy In Action: The American Society Of Hematology (ASH) 2013
Feb
06
2014

Vital Options International presents Advocacy In Action®, bringing together cancer advocacy leadership to address: The Future of Genomics & Personalized Medicine, Cancer Care Planning & Palliative Care, and Public Policy & Issues Surrounding the Affordable Care Act (ACA) Joining Vital Options CEO, Selma Schimmel — The Future of Genomics & Personalized Medicine: Keith Stewart, MD, […]

Read More
Public Policy & Issues Surrounding the Affordable Care Act – Helping Patients Get Ahead
Feb
06
2014

Joining Vital Options CEO, Selma Schimmel — Public Policy & Issues Surrounding the Affordable Care Act (ACA) — Meghan Gutierrez, Lymphoma Research Foundation (LRF); Michael Mauro, MD, Memorial Sloan-Kettering Cancer Center; Scott Riccio, Leukemia and Lymphoma Society (LLS). In this segment the panel discusses the things patients should know and questions they should ask to […]

Read More
Public Policy & Issues Surrounding the Affordable Care Act – Challenges In Access To Care
Feb
06
2014

Joining Vital Options CEO, Selma Schimmel — Public Policy & Issues Surrounding the Affordable Care Act (ACA) — Meghan Gutierrez, Lymphoma Research Foundation (LRF); Michael Mauro, MD, Memorial Sloan-Kettering Cancer Center; Scott Riccio, Leukemia and Lymphoma Society (LLS). In this segment the panel discusses the current challenges in access to care specifically for cancer patients.

Read More
Public Policy & Issues Surrounding the Affordable Care Act – The Affordable Care Act Challenges
Feb
06
2014

Joining Vital Options CEO, Selma Schimmel — Public Policy & Issues Surrounding the Affordable Care Act (ACA) — Meghan Gutierrez, Lymphoma Research Foundation (LRF); Michael Mauro, MD, Memorial Sloan-Kettering Cancer Center; Scott Riccio, Leukemia and Lymphoma Society (LLS). In this segment the panel discusses the specific challenges the Affordable Care Act is presenting for cancer […]

Read More
Public Policy & Issues Surrounding the Affordable Care Act – Clinician As a Public Policy Advocate
Feb
06
2014

Joining Vital Options CEO, Selma Schimmel — Public Policy & Issues Surrounding the Affordable Care Act (ACA) – Meghan Gutierrez, Lymphoma Research Foundation (LRF); Michael Mauro, MD, Memorial Sloan-Kettering Cancer Center; Scott Riccio, Leukemia and Lymphoma Society (LLS). In this segment Selma and Dr. Mauro discuss how he came to be a public policy advocate […]

Read More
Public Policy & Issues Surrounding the Affordable Care Act – What Is Public Policy?
Feb
06
2014

Joining Vital Options CEO, Selma Schimmel — Public Policy & Issues Surrounding the Affordable Care Act (ACA) — Meghan Gutierrez, Lymphoma Research Foundation (LRF); Michael Mauro, MD, Memorial Sloan-Kettering Cancer Center; Scott Riccio, Leukemia and Lymphoma Society (LLS). In this segment public policy as it relates to cancer advocacy is defined.

Read More
Cancer Care Planning & Palliative Care: Defining & Redefining
Feb
06
2014

Joining Vital Options CEO, Selma Schimmel — Cancer Care Planning & Palliative Care: Thomas LeBlanc, MD, Duke University Medical Center; Meghan Gutierrez, Lymphoma  Research Foundation (LRF); Scott Riccio, Leukemia and Lymphoma Society (LLS) In this segment the panel discusses the need for an evolution in the definition of palliative care and cancer care planning.

Read More
Cancer Care Planning & Palliative Care: Advocates & Clinicians Working Together
Feb
06
2014

Joining Vital Options CEO, Selma Schimmel — Cancer Care Planning & Palliative Care: Thomas LeBlanc, MD, Duke University Medical Center; Meghan Gutierrez, Lymphoma  Research Foundation (LRF); Scott Riccio, Leukemia and Lymphoma Society (LLS) In this segment the panel discusses what the clinicians need from the advocate community to help with palliative care and cancer care […]

Read More
Cancer Care Planning & Palliative Care: Hematologic Treatment Side Effects
Feb
06
2014

Joining Vital Options CEO, Selma Schimmel — Cancer Care Planning & Palliative Care: Thomas LeBlanc, MD, Duke University Medical Center; Meghan Gutierrez, Lymphoma  Research Foundation (LRF); Scott Riccio, Leukemia and Lymphoma Society (LLS) In this segment the panel discusses the hematologic treatment side effects associated with palliative care.

Read More
ASH 2013: The Future of Genomics & Personalized Medicine: Closing Thoughts From the Panel
Feb
06
2014

Joining Vital Options CEO, Selma Schimmel — The Future of Genomics & Personalized Medicine: Keith Stewart, MD, Mayo Clinic; Anne Quinn Young, MPH, Multiple Myeloma Research Foundation (MMF); Scott Riccio, Leukemia and Lymphoma Society (LLS); Meghan Gutierrez, Lymphoma Research Foundation (LRF). In this segment the panel discusses their closing thoughts on the topic of genomics […]

Read More